Protagonist Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 9.74 M | $470.87 M | -1.50% | 15.46% |
FARALLON CAPITAL MANAGEMENT LLC | 05/15/2025 | 6.11 M | $295.33 M | 2.98% | 9.70% |
RTW INVESTMENTS, LP | 05/15/2025 | 5.72 M | $276.59 M | 4.02% | 9.08% |
VANGUARD GROUP INC | 05/09/2025 | 4.28 M | $206.85 M | 1.36% | 6.79% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 3.00 M | $145.08 M | 200.00% | 4.76% |
STATE STREET CORP | 05/15/2025 | 2.71 M | $130.89 M | -18.75% | 4.30% |
BVF INC/IL | 05/15/2025 | 2.58 M | $124.53 M | 35.53% | 4.09% |
JOHNSON & JOHNSON | 05/07/2025 | 2.45 M | $118.44 M | 0.00% | 3.89% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.42 M | $68.86 M | 3.38% | 2.26% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.32 M | $63.93 M | -5.07% | 2.10% |
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 1.09 M | $52.77 M | -14.19% | 1.73% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 987.37 K | $47.75 M | 5.03% | 1.57% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 939.67 K | $45.44 M | -7.91% | 1.49% |
WOODLINE PARTNERS LP | 05/15/2025 | 897.70 K | $43.41 M | 54.16% | 1.43% |
INVESCO LTD. | 05/12/2025 | 859.65 K | $41.57 M | 16.33% | 1.37% |
LYNX1 CAPITAL MANAGEMENT LP | 05/15/2025 | 733.01 K | $35.45 M | 100.00% | 1.16% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 685.82 K | $33.17 M | -26.12% | 1.09% |
NORTHERN TRUST CORP | 05/13/2025 | 639.51 K | $30.93 M | 1.74% | 1.02% |
JEFFERIES FINANCIAL GROUP INC. | 05/08/2025 | 631.89 K | $30.56 M | -57.58% | 1.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 557.72 K | $26.97 M | -3.58% | 0.89% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 555.55 K | $26.87 M | -26.78% | 0.88% |
EVERSEPT PARTNERS, LP | 05/15/2025 | 547.12 K | $26.46 M | -19.40% | 0.87% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 500.00 K | $24.18 M | 21.95% | 0.79% |
MORGAN STANLEY | 05/15/2025 | 497.11 K | $24.04 M | -8.00% | 0.79% |
FMR LLC | 05/12/2025 | 478.34 K | $23.13 M | 8.10% | 0.76% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 471.75 K | $22.81 M | 249.77% | 0.75% |
JPMORGAN CHASE & CO | 05/12/2025 | 468.90 K | $22.68 M | -18.73% | 0.74% |
TORONTO DOMINION BANK | 05/15/2025 | 445.44 K | $21.54 M | 30.64% | 0.71% |
COLONY GROUP, LLC | 05/20/2025 | 435.10 K | $21.04 M | 2.24% | 0.69% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 400.00 K | $19.34 M | 207.69% | 0.64% |
MANGROVE PARTNERS | 05/15/2025 | 395.38 K | $19.12 M | 0.00% | 0.63% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2025 | 379.65 K | $18.36 M | 201.55% | 0.60% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 376.86 K | $18.23 M | -3.56% | 0.60% |
UBS GROUP AG | 05/13/2025 | 352.87 K | $17.06 M | 166.10% | 0.56% |
NEW VERNON CAPITAL HOLDINGS II LLC | 05/15/2025 | 348.10 K | $7.20 M | 11,271.94% | 0.55% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 347.10 K | $16.79 M | 2.75% | 0.55% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 343.50 K | $16.61 M | 100.00% | 0.55% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 343.41 K | $16.61 M | 9.96% | 0.55% |
ARTIA GLOBAL PARTNERS LP | 05/15/2025 | 333.85 K | $16.15 M | 13.61% | 0.53% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 323.57 K | $15.65 M | 46.30% | 0.51% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 298.83 K | $14.45 M | -1.48% | 0.47% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 295.59 K | $14.29 M | -0.31% | 0.47% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 288.60 K | $13.96 M | 100.00% | 0.46% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 287.30 K | $13.89 M | 100.00% | 0.46% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 05/07/2025 | 248.95 K | $12.04 M | -19.86% | 0.40% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 235.07 K | $11.37 M | -30.80% | 0.37% |
UBS ASSET MANAGEMENT AMERICAS INC | 05/19/2025 | 208.76 K | $10.10 M | -27.49% | 0.33% |
BURNEY CO/ | 05/06/2025 | 201.99 K | $9.77 M | 100.00% | 0.32% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 193.90 K | $9.38 M | 117.38% | 0.31% |
JANE STREET GROUP, LLC | 05/19/2025 | 193.30 K | $9.35 M | 214.05% | 0.31% |
Protagonist Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 326 institutional investors and hedge funds held shares of Protagonist Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 9.74 M
FARALLON CAPITAL MANAGEMENT LLC: 6.11 M
RTW INVESTMENTS, LP: 5.72 M
VANGUARD GROUP INC: 4.28 M
Deep Track Capital, LP: 3 M
STATE STREET CORP: 2.71 M
103.67% of Protagonist Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 76.20 M shares in the last 24 months. This purchase volume represents approximately $3.89 B in transactions.